-0.04%
Today
Loading 1D prices…
Company profile
Nurix Therapeutics Inc. Common stock is classified in Biotechnology: Pharmaceutical Preparations within the Health Care sector.
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
BRISBANE, CA, United States
Fiscal year end
1130
CIK
1549595
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LLYEli Lilly and Company Common Stock | $1.02T | $65.2B | +31.67% | $22.95 | -2.40% | Buy |
| JNJJohnson & Johnson Common Stock | $617.8B | $94.2B | +28.46% | $11.03 | -0.74% | Buy |
| ABBVAbbVie Inc. Common Stock | $443.4B | $61.2B | +6.91% | $2.36 | -2.35% | Buy |
| MRKMerck & Company Inc. Common Stock (new) | $321.6B | $65.0B | +28.08% | $7.28 | -1.87% | Buy |
| ABTAbbott Laboratories Common Stock | $184.1B | $44.3B | +14.72% | $3.72 | +1.37% | Buy |
